FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Ettinger

Research Profile

Disorders

Procedures

Chemicals & Drugs

Activities & Behaviors

Drug Evaluation

Concepts & Ideas

Co-author Network

Publications

TOP 3
Charles M Rudin; Rosa Sebree; Ruth Smith; Blake Aftab; Julie R Brahmer; David S Ettinger; Christine L Hann; Peng Huang; Rosalyn A Juergens; Jun O Liu
Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancer.
Richard C Wender; Andrew M D Wolf; G Scott Gazelle; Daniel C Sullivan; William Travis; Louise Walter; Ermilo Barrera; Otis W Brawley; Timothy R Church; Graham A Colditz; David S Ettinger; Ruth Etzioni; Christopher R Flowers; Elizabeth T H Fontham; Douglas K Kelsey; Samuel J LaMonte; James S Michaelson; Kevin C Oeffinger; Ya-Chen Tina Shih; Robert A Smith
American Cancer Society lung cancer screening guidelines.
Amy K Ferketich; Gregory P Kalemkerian; Rizvan Mamet; Joyce C Niland; Thomas A D'Amico; David S Ettinger; Katherine M Pisters; Mary E Reid; Carrie Zornosa; Gregory A Otterson
Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Ettinger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Charles M Rudin; Rosa Sebree; Ruth Smith; Blake Aftab; Julie R Brahmer; David S Ettinger; Christine L Hann; Peng Huang; Rosalyn A Juergens; Jun O Liu
Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2013;8(5):619-23.
2013: Richard C Wender; Andrew M D Wolf; G Scott Gazelle; Daniel C Sullivan; William Travis; Louise Walter; Ermilo Barrera; Otis W Brawley; Timothy R Church; Graham A Colditz; David S Ettinger; Ruth Etzioni; Christopher R Flowers; Elizabeth T H Fontham; Douglas K Kelsey; Samuel J LaMonte; James S Michaelson; Kevin C Oeffinger; Ya-Chen Tina Shih; Robert A Smith
American Cancer Society lung cancer screening guidelines.
CA: a cancer journal for clinicians 2013;63(2):107-17.
2013: Amy K Ferketich; Gregory P Kalemkerian; Rizvan Mamet; Joyce C Niland; Thomas A D'Amico; David S Ettinger; Katherine M Pisters; Mary E Reid; Carrie Zornosa; Gregory A Otterson
Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort.
Cancer 2013;119(4):847-53.
2012: David S Ettinger; Apar Kishor P Ganti; Ramaswamy Govindan; Frederic W Grannis; Kristina M Gregory; Leora Horn; Miranda Hughes; Thierry M Jahan; Mohammad Jahanzeb; Anne Kessinger; Ritsuko Komaki; Fengming P Kong; Mark G Kris; Lee M Krug; Inga T Lennes; Billy W Loo; Renato Martins; Janis O'Malley; Raymond U Osarogiagbon; Gregory A Otterson; Jyoti D Patel; Mary C Pinder-Schenck; Katherine M Pisters; Karen Reckamp; Gregory J Riely; Eric Rohren; Scott J Swanson; Douglas E Wood; Stephen C Yang; Wallace Akerley; Hossein Borghaei; Andrew C Chang; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy
Non-small cell lung cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(10):1236-71.
2012: Ritsuko Komaki; Corey J Langer; Rebecca Paulus; William T Sause; Gregory M M Videtic; Jeffrey D Bradley; Walter J. CURRAN; David S Ettinger; Bonnie S Glisson; Hak Choy
Phase II study of accelerated high-dose radiotherapy with concurrent chemotherapy for patients with limited small-cell lung cancer: Radiation Therapy Oncology Group protocol 0239.
International journal of radiation oncology, biology, physics 2012;83(4):e531-6.
2012: Carrie Zornosa; Michael S Rabin; Mary Reid; Jonathan L Vandergrift; Thomas A D'Amico; David S Ettinger; Gregory P Kalemkerian; Marianna Koczywas; Rizvan Mamet; Joyce C Niland; Gregory A Otterson; Katherine M Pisters
First-line systemic therapy practice patterns and concordance with NCCN guidelines for patients diagnosed with metastatic NSCLC treated at NCCN institutions.
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(7):847-56.
2012: David S Ettinger; Steve Kirkegaard; Dwight D Kloth; Mark G Kris; Dean Lim; Laura Boehnke Michaud; Lida Nabati; Kimberly Noonan; Hope S Rugo; Darby Siler; Steven M Sorscher; Sundae Stelts; Lisa Stucky-Marshall; Barbara Todaro; Susan G Urba; Debra K Armstrong; Sally Barbour; Michael J Berger; Philip J Bierman; Bob Bradbury; Georgianna Ellis
Antiemesis.
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(4):456-85.
2012: David S Ettinger
Ten years of progress in non-small cell lung cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(3):292-5.
2012: Douglas E Wood; George A Eapen; David S Ettinger; Lifang Hou; David Jackman; Ella Annabelle Kazerooni; Donald Klippenstein; Rudy P Lackner; Lorriana Leard; Ann N C Leung; Pierre P Massion; Bryan F Meyers; Reginald F Munden; Gregory A Otterson; KIMBERLY PEAIRS; Sudhakar Pipavath; Christie Pratt-Pozo; Chakravarthy Reddy; Mary E Reid; Arnold J Rotter; Matthew B Schabath; Lecia V Sequist; Betty C Tong; William D Travis; Michael Unger; Stephen C Yang
Lung cancer screening.
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(2):240-65.
2012: J M Kane; William G Kraybill; David R Lucas; D Wang; Walter J. CURRAN; Thomas F DeLaney; David S Ettinger; David C Harmon; J Harris; Burton L Eisenberg
Thromboembolic Events Associated with Thalidomide and Multimodality Therapy for Soft Tissue Sarcomas: Results of RTOG 0330.
Sarcoma 2012;2012():659485.
2012: David S Ettinger; Gregory J Riely; Billy W Loo; Mary Pinder Schenck; Richard T Cheney; Katherine M Pisters; Douglas E Wood; Mohammad Jahanzeb; Todd L Demmy; Frederic W Grannis; Fengming P Kong; Lee M Krug; Ritsuko Komaki; Renato Martins; Eric Rohren; Gregory A Otterson; Stephen C Yang; Wallace Akerley; Thierry M Jahan; Thomas A D'Amico; Ramaswamy Govindan; Andrew C Chang; Apar Kishor P Ganti; Scott J Swanson; Lucian R Chirieac; Hossein Borghaei; Karen Reckamp; Jyoti D Patel; Janis O'Malley; Inga T Lennes; Anne Kessinger; Mark G Kris; Leora Horn; Raymond U Osarogiagbon
Malignant pleural mesothelioma.
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(1):26-41.
2011: David S Ettinger; Mihaela Cristea; John Phay; Panagiotis M Fidias; Charles Russell Handorf; Leonard Saltz; Crystal S Denlinger; Mark Agulnik; Gauri R Varadhachary; Renato Lenzi; Asif Rashid; Renuka Iyer; David Gierada; Keith D Eaton; Jon P Gockerman; Justin M M Cates; Lawrence N Shulman; Jonathan S Zager; Weining Ken Zhen; Jeffrey B Smerage
Occult primary.
Journal of the National Comprehensive Cancer Network : JNCCN 2011;9(12):1358-95.
2011: Scott Okuno; Douglas Adkins; Howard Bailey; Charles Erlichman; David S Ettinger; Tom Fitch; Michelle R Mahoney; William Maples; Jann N. Sarkaria
A phase 2 study of temsirolimus (CCI-779) in patients with soft tissue sarcomas: a study of the Mayo phase 2 consortium (P2C).
Cancer 2011;117(15):3468-75.
2011: Lee M Krug; Jeffrey Crawford; David S Ettinger; Geoffrey I Shapiro; David Spigel; Tony Reiman; Jennifer S Temel; Glenn C Michelson; Donald Y Young; Ute Hoch; Daniel C Adelman
Phase II multicenter trial of voreloxin as second-line therapy in chemotherapy-sensitive or refractory small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(2):384-6.
2011: Karynsa Cetin; David S Ettinger; Yong-Jiang Hei; Cynthia D O'Malley
Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program.
Clinical epidemiology 2011;3():139-48.
2010: David S Ettinger; Wallace Akerley; Gerold Bepler; Matthew G Blum; Andrew C Chang; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Ramaswamy Govindan; Frederic W Grannis; Thierry Jahan; David H Johnson; Anne Kessinger; Ritsuko Komaki; Fengming P Kong; Mark G Kris; Lee M Krug; Quynh-Thu Le; Inga T Lennes; Renato Martins; Janis O'Malley; Raymond U Osarogiagbon; Gregory A Otterson; Jyoti D Patel; Katherine M Pisters; Karen Reckamp; Gregory J Riely; Eric Rohren; Scott J Swanson; Douglas E Wood; Stephen C Yang
Thymic malignancies.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8(11):1302-15.
2010: William G Kraybill; Jonathan Harris; Ira J Spiro; David S Ettinger; Thomas F DeLaney; Ronald Blum; David R Lucas; David C Harmon; G Douglas Letson; Burton Eisenberg
Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.
Cancer 2010;116(19):4613-21.
2010: Abdul-Rahman Jazieh; Hanaa Bamefleh; Ahmet Demirkazik; Rabab Mohamed Gaafar; Fady B Geara; Mansur Javaid; Jamal Khader; Kian Khodadad; Walid Omar; Ahmed Saadeddin; Hassan Al Sabe; Mohammad-Behgam Shadmehr; Amgad ElSherif; Najam Uddin; Mohammad Jahanzeb; David S Ettinger
Modification and implementation of NCCN guidelines on non-small cell lung cancer in the Middle East and North Africa region.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8 Suppl 3():S16-21.
2010: David S Ettinger; Wallace Akerley; Gerold Bepler; Matthew G Blum; Andrew C Chang; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Apar Kishor P Ganti; Ramaswamy Govindan; Frederic W Grannis; Thierry Jahan; Mohammad Jahanzeb; David H Johnson; Anne Kessinger; Ritsuko Komaki; Fengming P Kong; Mark G Kris; Lee M Krug; Quynh-Thu Le; Inga T Lennes; Renato Martins; Janis O'Malley; Raymond U Osarogiagbon; Gregory A Otterson; Jyoti D Patel; Katherine M Pisters; Karen Reckamp; Gregory J Riely; Eric Rohren; George R Simon; Scott J Swanson; Douglas E Wood; Stephen C Yang
Non-small cell lung cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8(7):740-801.
2010: Seena Aisner; Suzanne Dahlberg; Meera Hameed; David S Ettinger; Joan H Schiller; David H Johnson; Joseph Aisner; Patrick J Loehrer
Epidermal growth factor receptor, C-kit, and Her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the 2004 World Health Organization in patients treated with octreotide and prednisone: an Eastern Cooperative Oncology Group study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(6):885-92.
2010: David S Ettinger
Emerging profile of cetuximab in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2010;68(3):332-7.
2010: David S Ettinger; Robert Jotte; Paul Lorigan; Vicram Gupta; Lawrence Garbo; Carlos Alemany; Paul Conkling; David R Spigel; Arkadiusz Z Dudek; Chirag Shah; Ravi Salgia; Richard McNally; Markus F Renschler; Jennifer W Oliver
Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(15):2598-603.
2010: Gary R Morrow; Lee S Schwartzberg; Paul J Hesketh; David S Ettinger
Recent Advances in the Management of Chemotherapy-induced Nausea and Vomiting: A Case Study Compendium.
Clinical advances in hematology & oncology : H&O 2010;8(5 Suppl 9):1-16.
2010: Ani Balmanoukian; David S Ettinger
Managing the patient with borderline resectable lung cancer.
Oncology (Williston Park, N.Y.) 2010;24(3):234-41.
2009: Michaela J Higgins; David S Ettinger
Chemotherapy for lung cancer: the state of the art in 2009.
Expert review of anticancer therapy 2009;9(10):1365-78.
2009: David S Ettinger; Debra K Armstrong; Sally Barbour; Michael J Berger; Philip J Bierman; Bob Bradbury; Georgianna Ellis; Steve Kirkegaard; Dwight D Kloth; Mark G Kris; Dean Lim; Michael Anne Markiewicz; Lida Nabati; Carli Nesheiwat; Hope S Rugo; Steven M Sorscher; Lisa Stucky-Marshal; Barbara Todaro; Susan G Urba
Antiemesis. Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(5):572-95.
2009: David S Ettinger; Steven M Grunberg; A Brett Hauber; Ateesha F Mohamed
Evaluation of the relative importance of chemotherapeutic and antiemetic efficacy in various oncologic settings.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2009;17(4):405-11.
2009: Michael J Guarino; Charles J Schneider; Martha A Hosford; Julie R Brahmer; Charles Rudin; Friedrich Graf Finckenstein; Robyn E Philip-Norton; Haolan Lu; Martin R Weber; David S Ettinger
Dual inhibition of the epidermal growth factor receptor pathway with cetuximab and erlotinib: a phase I study in patients with advanced solid malignancies.
The oncologist 2009;14(2):119-24.
2009: Hak Choy; Anshu K Jain; Jennifer Moughan; Walter Curran; Gary Whipple; William F Demas; David S Ettinger
RTOG 0017: a phase I trial of concurrent gemcitabine/carboplatin or gemcitabine/paclitaxel and radiation therapy ("ping-pong trial") followed by adjuvant chemotherapy for patients with favorable prognosis inoperable stage IIIA/B non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(1):80-6.
2008: Wells A Messersmith; Antonio Jimeno; David S Ettinger; Daniel Laheru; Julie R Brahmer; Dina Lansey; Yasmin Khan; Ross C Donehower; Yusri Elsayed; Peter Zannikos; Manuel Hidalgo
Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2008;63(1):181-8.
2008: David S Ettinger; Mark Agulnik; Mihaela Cristea; Keith Eaton; Panagiotis M Fidias; Jon P Gockerman; Omar Hameed; Charles Handorf; Elizabeth I Harris; Charlotte D Jacobs; Milind Javle; Nikhil I Khushalani; Larry Kvols; Renato Lenzi; Nancy L Lewis; Asif Rashid; Leonard B Saltz; Lawrence N Shulman; Jonathan S Zager; Weining Zhen
Occult primary.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(10):1026-60.
2008: Robert A Figlin; Elizabeth Brown; Andrew J Armstrong; Wallace Akerley; Al B Benson; Harold J Burstein; David S Ettinger; Phillip G Febbo; Matthew G Fury; Gary R Hudes; Merrill S Kies; Eunice L Kwak; Robert J Morgan; Joanne Mortimer; Karen Reckamp; Alan P Venook; Frank Worden; Yun Yen
NCCN Task Force Report: mTOR inhibition in solid tumors.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6 Suppl 5():S1-20; quiz S21-2.
2008: Gregory P Kalemkerian; Wallace Akerley; Robert J Downey; David S Ettinger; Frank Fossella; John C Grecula; Thierry jahan; Bruce E Johnson; Anne Kessinger; Marianna Koczywas; Corey J Langer; Renato Martins; Harvey B Niell; charlie Pan; Nithya Ramnath; Neal Ready; Francisco Robert; Charles C Williams
Small cell lung cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(3):294-314.
2008: David S Ettinger; Wallace Akerley; Gerold Bepler; Andrew C Chang; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Steven Feigenberg; Robert A Figlin; Ramaswamy Govindan; Frederic W Grannis; Thierry jahan; Mohammad Jahanzeb; Anne Kessinger; Ritsuko Komaki; Mark G Kris; Corey J Langer; Quynh-Thu Le; Renato Martins; Gregory A Otterson; Jyoti D Patel; Francisco Robert; David J Sugarbaker; Douglas E Wood
Non-small cell lung cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(3):228-69.
2007: George D Demetri; Robert S Benjamin; Charles D Blanke; Jean-Yves Blay; Paolo Casali; Haesun Choi; Christopher L Corless; Maria Debiec-Rychter; Ronald P DeMatteo; David S Ettinger; George A Fisher; Christopher D M Fletcher; Alessandro Gronchi; Peter Hohenberger; Miranda Hughes; Heikki Joensuu; Ian Judson; Axel Le Cesne; ROBERT G MAKI; Michael Morse; Alberto S Pappo; Peter W T Pisters; Chandrajit P Raut; Peter Reichardt; Douglas S Tyler; Annick D Van den Abbeele; Margaret von Mehren; Jeffrey D Wayne; John Zalcberg
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5 Suppl 2():S1-29; quiz S30.
2007: Julie R Brahmer; David S Ettinger
Non-small cell lung cancer: adjuvant and neo-adjuvant chemotherapy.
Respirology (Carlton, Vic.) 2007;12(3):320-5.
2007: Donald A Podoloff; Ranjana Advani; Craig Allred; Al B Benson; Elizabeth Brown; Harold J Burstein; Robert W Carlson; R Edward Coleman; Myron S Czuczman; Dominique Delbeke; Stephen B Edge; David S Ettinger; Frederic W Grannis; bruce hillner; John M Hoffman; Krystyna Kiel; Ritsuko Komaki; Steven M Larson; David A Mankoff; Kenneth E Rosenzweig; John M Skibber; Joachim Yahalom; Jq Michael Yu; Andrew D Zelenetz
NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5 Suppl 1():S1-22; quiz S23-2.
2007: George D Demetri; Laurence H Baker; Robert S Benjamin; Ephraim S Casper; Ernest U Conrad; Gina Z D'Amato; Thomas F DeLaney; David S Ettinger; Robert K Heck; Martin J Heslin; Raymond J Hutchinson; Charlotte D Jacobs; Krystyna Kiel; William G Kraybill; G Douglas Letson; Richard J O'Donnell; I Benjamin Paz; John Pfeifer; Raphael E Pollock; R Lor Randall; Aaron R Sasson; Karen D Schupak; Douglas S Tyler; Margaret von Mehren; Jeffrey Wayne
Soft tissue sarcoma.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(4):364-99.
2007: Rosalyn A Juergens; Julie R Brahmer; David S Ettinger
Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter.
Cancer chemotherapy and pharmacology 2007;59(5):621-9.
2007: David S Ettinger
Amrubicin for the treatment of small cell lung cancer: does effectiveness cross the Pacific?
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(2):160-5.
2007: David S Ettinger; Philip J Bierman; Bob Bradbury; Carli C Comish; Georgiana Ellis; Robert J Ignoffo; Steve Kirkegaard; Dwight D Kloth; Mark G Kris; Dean Lim; Michael Anne Markiewicz; Robert McNulty; Lidia Nabati; Barbara Todaro; Susan G Urba; Sally Yowell
Antiemesis.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(1):12-33.
2006: Howard H Bailey; Michelle R Mahoney; David S Ettinger; William J Maples; Paula M Fracasso; Anne M Traynor; Charles Erlichman; Scott H Okuno
Phase II study of daily oral perifosine in patients with advanced soft tissue sarcoma.
Cancer 2006;107(10):2462-7.
2006: David S Ettinger; Joseph Aisner
Changing face of small-cell lung cancer: real and artifact.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(28):4526-7.
2006: Bruce E Johnson; Jeffrey Crawford; Robert J Downey; David S Ettinger; Frank Fossella; John C Grecula; Thierry jahan; Gregory P Kalemkerian; Anne Kessinger; Marianna Koczywas; Corey J Langer; Renato Martins; Maryanne Hoffman Marymont; Harvey B Niell; Nithya Ramnath; Francisco Robert; Charles C Williams
Small cell lung cancer clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(6):602-22.
2006: David S Ettinger; Gerold Bepler; Raphael Bueno; Andrew C Chang; Joe Y Chang; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Steven Feigenberg; Frederic W Grannis; Thierry jahan; Mohammad Jahanzeb; Anne Kessinger; Ritsuko Komaki; Mark G Kris; Corey J Langer; Quynh-Thu Le; Renato Martins; Gregory A Otterson; Francisco Robert; David J Sugarbaker; Douglas E Wood
Non-small cell lung cancer clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(6):548-82.
2006: David S Ettinger
Clinical implications of EGFR expression in the development and progression of solid tumors: focus on non-small cell lung cancer.
The oncologist 2006;11(4):358-73.
2006: Orlo H Clark; Jaffer A Ajani; Al B Benson; David Byrd; Gerard M Doherty; Paul F Engstrom; David S Ettinger; John F Gibbs; Martin J Heslin; Fouad Kandeel; Anne Kessinger; Matthew H Kulke; Larry K Kvols; Albert A Nemcek; John Olson; Thomas W Ratliff; Leonard B Saltz; David E Schteingart; Manisha H Shah; Stephen Shibata
Neuroendocrine tumors.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(2):102-38.
2006: William G Kraybill; Jonathon Harris; Ira J Spiro; David S Ettinger; Thomas F DeLaney; Ronald Blum; David R Lucas; David C Harmon; G Douglas Letson; Burton L Eisenberg
Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(4):619-25.
2005: David S Ettinger; Bruce Johnson
Update: NCCN small cell and non-small cell lung cancer Clinical Practice Guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3 Suppl 1():S17-21.
2005: David S Ettinger; Brian A Berkey; Ross A. Abrams; James Fontanesi; Mitchell Machtay; Philip J Duncan; Walter Curran; Benjamin Movsas; Roger W. Byhardt
Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):4991-8.
2005: Lodovico Balducci; Harvey Jay Cohen; Paul F Engstrom; David S Ettinger; Jeffrey Halter; Leo I Gordon; Krystyna Kiel; Andrew Kneier; Dean Lim; Stephen H Petersdorf; Ronnie Rosenthal; Rebecca Silliman; Julie M Vose; Michael J Walker; Babu Zachariah
Senior adult oncology clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(4):572-90.
2005: Ritsuko Komaki; R Suzanne Swann; David S Ettinger; Bonnie S Glisson; Alan B Sandler; Benjamin Movsas; John Suh; Roger W. Byhardt
Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12.
International journal of radiation oncology, biology, physics 2005;62(2):342-50.
2005: Jeffrey D. Bradley; Rebecca Paulus; Mary V Graham; David S Ettinger; David W Johnstone; Miljenko V Pilepich; Mitchell Machtay; Ritsuko Komaki; James Atkins; Walter Curran
Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3480-7.
2005: Scott Okuno; William J Maples; Michelle R Mahoney; Tom R Fitch; James A Stewart; Paula M Fracasso; Michael Kraut; David S Ettinger; Fitzroy W Dawkins; Charles Erlichman
Evaluation of epothilone B analog in advanced soft tissue sarcoma: a phase II study of the phase II consortium.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(13):3069-73.
2005: David S Ettinger
An overview of Eastern Cooperative Oncology Group stage III non-small cell lung cancer studies.
Seminars in oncology 2005;32(2 Suppl 3):S109-10.
2005: David S Ettinger
Non-small cell lung cancer treatment-related bone marrow toxicities.
Seminars in oncology 2005;32(2 Suppl 3):S81-5.
2005: Corey J Langer; Jennifer Moughan; Benjamin Movsas; Ritsuko Komaki; David S Ettinger; Jean Owen; J Frank Wilson
Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
Lung cancer (Amsterdam, Netherlands) 2005;48(1):93-102.
2005: David S Ettinger; Juan P Arnoletti; Jon P Gockerman; Charles Handorf; Kathleen Anne Havlin; Charlotte D Jacobs; Milind Javle; Larry Kvols; Renato Lenzi; Asif Rashid; Chris A Rhoades; John A Ridge; Leonard B Saltz; Lawrence N Shulman; Vernon K Sondak; John A Thompson; Przemyslaw Twardowski; Weining Zhen
Occult primary cancer clinical practice guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(2):214-33.
2005: George D Demetri; Laurence H Baker; Derrick J Beech; Robert Benjamin; Ephraim S Casper; Ernest U Conrad; Thomas F DeLaney; David S Ettinger; Martin J Heslin; Raymond J Hutchinson; Krystyna Kiel; William G Kraybill; G Douglas Letson; James Neff; Richard J O'Donnell; I Benjamin Paz; Raphael E Pollock; R Lor Randall; Karen D Schupak; Douglas S Tyler; Margaret von Mehren; Jeffrey Wayne
Soft tissue sarcoma clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(2):158-94.
2005: Malcolm V Brock; Craig M Hooker; James E Syphard; William H Westra; Li Xu; Anthony J Alberg; David Mason; Stephen B Baylin; James G Herman; Rex C-W Yung; Julie R Brahmer; Charles Rudin; David S Ettinger; Stephen C Yang
Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come.
The Journal of thoracic and cardiovascular surgery 2005;129(1):64-72.
2004: David S Ettinger; Mark G Kris
Update: NCCN non-small cell lung cancer clinical practice guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN 2004;2 Suppl 3():S-9-13.
2004: David S Ettinger; Philip J Bierman; Bob Bradbury; Georgiana Ellis; Robert J Ignoffo; Steve Kirkegaard; Dwight Kloth; Amy Krauss; Mark G Kris; Dean Lim; Michael Anne Markiewicz; Robert McNulty; Kim Noonan; Lisa Stucky-Marshall; Barbara Todaro; Susan G Urba; Sally Yowell
Antiemesis clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2004;2(5):470-90.
2004: Christian Monnerat; Thierry Le Chevalier; Karen Kelly; Coleman K Obasaju; Julie R Brahmer; Silvia Novello; Takashi Nakamura; Astra M Liepa; Laurence Bozec; Paul A Bunn; David S Ettinger
Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5439-46.
2004: David S Ettinger
Overview and state of the art in the management of lung cancer.
Oncology (Williston Park, N.Y.) 2004;18(7 Suppl 4):3-9.
2004: Alexander Spira; David S Ettinger
Multidisciplinary management of lung cancer.
The New England journal of medicine 2004;350(4):379-92.
2004: Patrick J Loehrer; Wei Wang; David H Johnson; Seena Aisner; David S Ettinger
Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(2):293-9.
2003: Benjamin Movsas; Jennifer Moughan; Ritsuko Komaki; H Choy; Roger W. Byhardt; Corey Langer; Melvyn Goldberg; M Graham; David S Ettinger; D Johnstone; R Abrams; Reginald F Munden; G Starkschall; Jean Owen
Radiotherapy patterns of care study in lung carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4553-9.
2003: W. PURCELL; David S Ettinger
Novel antifolate drugs.
Current oncology reports 2003;5(2):114-25.
2003: Alexander Spira; David S Ettinger
Extensive-stage small-cell lung cancer.
Seminars in surgical oncology 2003;21(3):164-75.
2002: David W Johnstone; Roger W. Byhardt; David S Ettinger; Charles B Scott
Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group.
International journal of radiation oncology, biology, physics 2002;54(2):365-9.
2002: David S Ettinger; Dianne M Finkelstein; Paul S Ritch; Sarah T Lincoln; Ronald Blum
Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588).
Lung cancer (Amsterdam, Netherlands) 2002;37(3):311-8.
2002: Ritsuko Komaki; Wendy Seiferheld; David S Ettinger; Jin S Lee; Benjamin Movsas; William T Sause
Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04.
International journal of radiation oncology, biology, physics 2002;53(3):548-57.
2002: David S Ettinger
Pemetrexed (Alimta): a new antifolate for non-small-cell lung cancer.
Clinical lung cancer 2002;3 Suppl 1():S22-5.
2002: Hillary A Hahm; David S Ettinger; Kathy Bowling; Beth Hoker; Tian Ling Chen; Yelena Zabelina; Robert A Casero
Phase I study of N(1),N(11)-diethylnorspermine in patients with non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(3):684-90.
2002: Jin S Lee; Charles B Scott; Ritsuko Komaki; David S Ettinger; William T Sause
Impact of institutional experience on survival outcome of patients undergoing combined chemoradiation therapy for inoperable non-small-cell lung cancer.
International journal of radiation oncology, biology, physics 2002;52(2):362-70.
2002: Alexander I Spira; David S Ettinger
The use of chemotherapy in soft-tissue sarcomas.
The oncologist 2002;7(4):348-59.
2002: David S Ettinger
Is there a preferred combination chemotherapy regimen for metastastic non-small cell lung cancer?
The oncologist 2002;7(3):226-33.
2001: David S Ettinger; Mark G Kris
NCCN: Non-small cell lung cancer.
Cancer control : journal of the Moffitt Cancer Center 2001;8(6 Suppl 2):22-31.
2001: David S Ettinger
New drugs for chemotherapy-naive patients with extensive-disease small cell lung cancer.
Seminars in oncology 2001;28(2 Suppl 4):27-9.
2001: J Ajani; David S Ettinger; David P Kelsen; Clifford Hudis; A Kudelka; C Langer; Kenneth J Pienta; H Safran; E E Vokes; W K Yung
Radiation Therapy Oncology Group. Research Plan 2002-2006. Medical Oncology Committee.
International journal of radiation oncology, biology, physics 2001;51(3 Suppl 2):88-91.
2001: B L Eisenburg; Kaled M. Alektiar; M Ballo; T F DeLaney; David S Ettinger; D Harmon; J Harris; M Joyce; William G Kraybill; S Leider; David R Lucas; I Peterson; R E Pollock; D Pritchard; H S Schwartz; A W Yasko; P T Pisters; S R Patel; J watson
Radiation Therapy Oncology Group. Research Plan 2002-2006. Sarcoma Committee.
International journal of radiation oncology, biology, physics 2001;51(3 Suppl 2):53-5.
2001: R Bynhardt; R Komaki; David S Ettinger; David W Johnstone; J Bradley; A Franko; L Gaspar; Michael T Gillin; C Langer; E Layne; Benjamin Movsas; Reginald F Munden; William T Sause; J Stern; J Hsu; W Hartsell; R Yesner
Radiation Therapy Oncology Group. Research Plan 2002-2006. Lung Cancer Committee.
International journal of radiation oncology, biology, physics 2001;51(3 Suppl 2):44-52.
2000: David S Ettinger
Gemcitabine plus radiation therapy in the treatment of locally advanced non small-cell lung cancer.
Clinical lung cancer 2000;2 Suppl 1():S33-8.
2000: David S Ettinger
Gemcitabine/Alimta in locally advanced or metastatic non-small-cell lung cancer.
Oncology (Williston Park, N.Y.) 2000;14(7 Suppl 4):49-52.
2000: David S Ettinger
Gemcitabine-containing regimens in non-small cell lung cancer: are these standard therapies or not?
Seminars in oncology 2000;27(1 Suppl 2):1-2.
2000: A R Yuen; J Z Fuks; David S Ettinger; ALEX CHANG; John Ruckdeschel; S C Phan; Ronald Blum
Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
The cancer journal from Scientific American 2000;6(1):34-9.
1999: Chandra P Belani; Phillip Bonomi; Tracy W Dobbs; Russell F DeVore; David S Ettinger; J Jett; James D Luketich; L J Cohen; David H Johnson
Docetaxel and cisplatin in patients with advanced non small-cell lung cancer (NSCLC): a multicenter phase II trial.
Clinical lung cancer 1999;1(2):144-50.
1999: Ming Teng; Hak Choy; David S Ettinger
Combined chemoradiation therapy for limited-stage small-cell lung cancer.
Oncology (Williston Park, N.Y.) 1999;13(10 Suppl 5):107-15.
1999: David S Ettinger
Concurrent paclitaxel-containing regimens and thoracic radiation therapy for limited-disease small cell lung cancer.
Seminars in radiation oncology 1999;9(2 Suppl 1):148-50.
1999: Alan B Sandler; David S Ettinger
Gemcitabine: single-agent and combination therapy in non-small cell lung cancer.
The oncologist 1999;4(3):241-51.
1999: Bennett B Chin; James S Welsh; Lawrence Kleinberg; David S Ettinger; P White
Nonsegmental ventilation-perfusion scintigraphy mismatch after radiation therapy.
Clinical nuclear medicine 1999;24(1):54-6.
1999: K Lin; Ba Duong Nguyen; David S Ettinger; Bennett B Chin
Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma.
Clinical nuclear medicine 1999;24(1):24-8.
1998: Gregory P Kalemkerian; M Jiroutek; David S Ettinger; J A Dorighi; D H Johnson; M Mabry
A phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma: an Eastern Cooperative Oncology Group Study.
Cancer 1998;83(6):1102-8.
1998: Richard J Gralla; Rudolph M Navari; Paul J Hesketh; W Popovic; J Strupp; J Noy; L Einhorn; David S Ettinger; W Bushnell; C Friedman
Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1568-73.
1998: R E Gregory; David S Ettinger
5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.
Drugs 1998;55(2):173-89.
1998: Howard Hochster; Ruth Oratz; David S Ettinger; Ernest C Borden
A phase II study of Didemnin B (NSC 325319) in advanced malignant melanoma: an Eastern Cooperative Oncology Group study (PB687).
Investigational new drugs 1998;16(3):259-63.
1998: David S Ettinger
Combined-modality treatment for stage IIIa (N2) non-small cell lung cancer: a National Cancer Institute Intergroup study.
Cancer chemotherapy and pharmacology 1998;42 Suppl():S71-4.
1998: D H Johnson; ALEX CHANG; David S Ettinger; K M Kim; P Bonomi
Recent advances with chemotherapy for NSCLC: the ECOG experience. Eastern Cooperative Oncology Group.
Oncology (Williston Park, N.Y.) 1998;12(1 Suppl 2):67-70.
1998: David S Ettinger
The role of carboplatin in the treatment of small-cell lung cancer.
Oncology (Williston Park, N.Y.) 1998;12(1 Suppl 2):36-43.
1998: J F Hermann; David S Ettinger; Richard Gams
The final dilemma. End-of-life treatment decisions.
Cancer practice 1998;6(1):57-9.
1997: Margaret A Tucker; N Murray; Edward G Shaw; David S Ettinger; M Mabry; M H Huber; R Feld; F A Shepherd; D H Johnson; S C Grant; Joseph Aisner; Bruce E Johnson
Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre.
Journal of the National Cancer Institute 1997;89(23):1782-8.
1997: P White; David S Ettinger
Tissue is the issue: is endoscopic ultrasonography with or without fine-needle aspiration biopsy in the staging of non-small-cell lung cancer an advance?
Annals of internal medicine 1997;127(8 Pt 1):643-5.
1997: Ritsuko Komaki; C Scott; David S Ettinger; Jin S Lee; Frank V Fossella; Walter Curran; R F Evans; Philip Rubin; Roger W. Byhardt
Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04.
International journal of radiation oncology, biology, physics 1997;38(1):149-55.
1997: Eric K Rowinsky; W A Flood; S E Sartorius; Kathy Bowling; David S Ettinger
Phase I study of paclitaxel on a 3-hour schedule followed by carboplatin in untreated patients with stage IV non-small cell lung cancer.
Investigational new drugs 1997;15(2):129-38.
1996: David S Ettinger
Single-agent paclitaxel in the treatment of small cell lung cancer.
Seminars in oncology 1996;23(6 Suppl 16):16-7.
1996: Eric K Rowinsky; Scott H Kaufmann; Sharyn D Baker; Louise B. Grochow; Tian Ling Chen; D Peereboom; M K Bowling; SE Sartorius; David S Ettinger; Arlene A Forastiere; Ross C Donehower
Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(12):3074-84.
1996: Seamus O'Reilly; Eric K Rowinsky; W Slichenmyer; Ross C Donehower; Arlene A Forastiere; David S Ettinger; Tian Ling Chen; SE Sartorius; Louise B. Grochow
Phase I and pharmacologic study of topotecan in patients with impaired renal function.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(12):3062-73.
1996: David S Ettinger; J D Cox; R J Ginsberg; R Komaki; Mark G Kris; R B Livingston; D J Sugarbaker
NCCN Non-Small-Cell Lung Cancer Practice Guidelines. The National Comprehensive Cancer Network.
Oncology (Williston Park, N.Y.) 1996;10(11 Suppl):81-111.
1996: David S Ettinger; P D Eisenberg; D Fitts; C Friedman; K Wilson-Lynch; K Yocom
A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy.
Cancer 1996;78(1):144-51.
1996: Seamus O'Reilly; Eric K Rowinsky; W Slichenmyer; Ross C Donehower; Arlene A Forastiere; David S Ettinger; Tian Ling Chen; SE Sartorius; Kathy Bowling; J Smith; A Brubaker; B Lubejko; V Ignacio; Louise B. Grochow
Phase I and pharmacologic studies of topotecan in patients with impaired hepatic function.
Journal of the National Cancer Institute 1996;88(12):817-24.
1996: David S Ettinger
Ifosfamide in the treatment of small cell lung cancer.
Seminars in oncology 1996;23(3 Suppl 6):2-6.
1995: Eric K Rowinsky; W A Flood; SE Sartorius; M K Bowling; J Wagner; David S Ettinger
Phase I study of paclitaxel as a 3-hour infusion followed by carboplatin in untreated patients with stage IV non-small cell lung cancer.
Seminars in oncology 1995;22(4 Suppl 9):48-54.
1995: David S Ettinger
Preventing chemotherapy-induced nausea and vomiting: an update and a review of emesis.
Seminars in oncology 1995;22(4 Suppl 10):6-18.
1995: Antonio C Wolff; David S Ettinger; D Neuberg; R L Comis; John Ruckdeschel; P D Bonomi; D H Johnson
Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(7):1615-22.
1995: David S Ettinger; D M Finkelstein; R P Sarma; D H Johnson
Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(6):1430-5.
1995: David S Ettinger
New drugs for treating small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1995;12 Suppl 3():S53-61.
1995: Roger W. Byhardt; Charles B Scott; David S Ettinger; Walter Curran; R L Doggett; C Coughlin; Charles Scarantino; Marvin Rotman; Bahman Emami
Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of Radiation Therapy Oncology Group 90-15.
Cancer 1995;75(9):2337-44.
1995: David S Ettinger
The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
Seminars in oncology 1995;22(1 Suppl 2):23-7.
1994: Eric K Rowinsky; D A Noe; D L Trump; Eric P Winer; V S Lucas; W A Wargin; JA Hohneker; B Lubejko; SE Sartorius; David S Ettinger
Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(9):1754-63.
1994: R E Lenhard; M J Daniels; M M Oken; J H Glick; David S Ettinger; L Kalish; M J O'Connell
An aggressive high dose cyclophosphamide and prednisone regimen for advanced multiple myeloma.
Leukemia & lymphoma 1994;13(5-6):485-9.
1994: R E Lenhard; L A Kalish; M M Oken; David S Ettinger; J Glick
Timed-sequential high-dose cyclophosphamide and vincristine in the treatment of multiple myeloma.
Cancer 1994;73(8):2113-8.
1994: J C Payne; R S Bergman; David S Ettinger
Endoscopic carpal tunnel release.
The Journal of the American Osteopathic Association 1994;94(4):295-8.
1994: Eric K Rowinsky; Louise B. Grochow; David S Ettinger; SE Sartorius; B G Lubejko; Tian Ling Chen; M K Rock; Ross C Donehower
Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks.
Cancer research 1994;54(2):427-36.
1994: J H Schiller; David S Ettinger; M M Larson; W Gradishar; D Merkel; D H Johnson
Phase II trial of oral etoposide plus cisplatin in extensive stage small cell carcinoma of the lung: an Eastern Cooperative Oncology Group study.
European journal of cancer (Oxford, England : 1990) 1994;30A(2):158-61.
1994: J M Borkowski; M Duerr; Ross C Donehower; eric rowinsky; T L Chen; David S Ettinger; Louise B. Grochow
Relation between age and clearance rate of nine investigational anticancer drugs from phase I pharmacokinetic data.
Cancer chemotherapy and pharmacology 1994;33(6):493-6.
1994: David H Johnson; ALEX CHANG; David S Ettinger
Taxol (paclitaxel) in the treatment of lung cancer: the Eastern Cooperative Oncology Group experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 6():S45-50.
1993: Eric K Rowinsky; Vinay Chaudhry; Arlene A Forastiere; SE Sartorius; David S Ettinger; Louise B. Grochow; B G Lubejko; David R Cornblath; Ross C Donehower
Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(10):2010-20.
1993: P D Bonomi; D Finkelstein; Seena Aisner; David S Ettinger
EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma.
American journal of clinical oncology 1993;16(4):342-5.
1993: David S Ettinger
Overview of paclitaxel (Taxol) in advanced lung cancer.
Seminars in oncology 1993;20(4 Suppl 3):46-9.
1993: David H Johnson; A T Turrisi; ALEX CHANG; Ronald Blum; P Bonomi; David S Ettinger; H Wagner
Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(5):879-84.
1993: Eric K Rowinsky; D A Noe; David S Ettinger; M C Christian; B G Lubejko; elliot fishman; SE Sartorius; M R Boyd; Ross C Donehower
Phase I and pharmacological study of the pulmonary cytotoxin 4-ipomeanol on a single dose schedule in lung cancer patients: hepatotoxicity is dose limiting in humans.
Cancer research 1993;53(8):1794-801.
1993: Stuart A Grossman; D M Finkelstein; John Ruckdeschel; D L Trump; T Moynihan; David S Ettinger
Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):561-9.
1993: FARIDEH MAJIDI; J P Enterline; B Ashley; M E Fowler; L L Ogorzalek; R Gaudette; G J Stuart; M Fulton; David S Ettinger
Chemotherapy and treatment scheduling: the Johns Hopkins Oncology Center Outpatient Department.
Proceedings / the ... Annual Symposium on Computer Application [sic] in Medical Care. Symposium on Computer Applications in Medical Care 1993;():154-8.
1993: David S Ettinger
Taxol in the treatment of lung cancer.
Journal of the National Cancer Institute. Monographs 1993;(15):177-9.
1992: David S Ettinger; D M Finkelstein; M D Abeloff; R T Skeel; P B Stott; M S Frontiera; P D Bonomi
Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study.
Journal of the National Cancer Institute 1992;84(14):1077-84.
1992: Eric K Rowinsky; Louise B. Grochow; C B Hendricks; David S Ettinger; Arlene A Forastiere; L A Hurowitz; W P McGuire; SE Sartorius; B G Lubejko; Scott H Kaufmann
Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(4):647-56.
1992: David S Ettinger
Overview of ifosfamide in small cell lung cancer.
Seminars in oncology 1992;19(1 Suppl 1):59-67.
1992: Carole B Miller; L C Platanias; S R Mills; Marianna Zahurak; Mark J Ratain; David S Ettinger; Richard J Jones
Phase I-II trial of erythropoietin in the treatment of cisplatin-associated anemia.
Journal of the National Cancer Institute 1992;84(2):98-103.
1992: J P Enterline; FARIDEH MAJIDI; L L Ogorzalek; G J Stuart; J S Rauch; M D Fulton; David S Ettinger
Integrated ambulatory care services in oncology.
Proceedings / the ... Annual Symposium on Computer Application [sic] in Medical Care. Symposium on Computer Applications in Medical Care 1992;():197-201.
1991: C B Hendricks; Louise B. Grochow; Eric K Rowinsky; Arlene A Forastiere; W P McGuire; David S Ettinger; SE Sartorius; B Lubejko; Ross C Donehower
Phase I and pharmacokinetic study of hepsulfam (NSC 329680).
Cancer research 1991;51(21):5781-5.
1991: G B Stillwagon; S E Order; TL Haulk; J Herpst; David S Ettinger; elliot fishman; J L Klein; PK Leichner
Variable low dose rate irradiation (131I-anti-CEA) and integrated low dose chemotherapy in the treatment of nonresectable primary intrahepatic cholangiocarcinoma.
International journal of radiation oncology, biology, physics 1991;21(6):1601-5.
1991: Eric K Rowinsky; M R Gilbert; W P McGuire; D A Noe; Louise B. Grochow; Arlene A Forastiere; David S Ettinger; B G Lubejko; B Clark; SE Sartorius
Sequences of taxol and cisplatin: a phase I and pharmacologic study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(9):1692-703.
1991: S Order; T Pajak; S Leibel; Sucha O Asbell; P Leichner; David S Ettinger; G Stillwagon; J Herpst; TL Haulk; K Kopher
A randomized prospective trial comparing full dose chemotherapy to 131I antiferritin: an RTOG study.
International journal of radiation oncology, biology, physics 1991;20(5):953-63.
1991: David S Ettinger; J D Bitran; R L Comis; C J Langer; K V Harwood; C L Harris; J H Keller; M Losada
Etoposide and mitomycin in the treatment of non-small-cell lung cancer. A phase I-II evaluation.
American journal of clinical oncology 1991;14(2):127-32.
1991: B Epstein; David S Ettinger; PK Leichner; S E Order
Multimodality cisplatin treatment in nonresectable alpha-fetoprotein-positive hepatoma.
Cancer 1991;67(4):896-900.
1990: D A Noe; Eric K Rowinsky; H S Shen; B V Clarke; Louise B. Grochow; W B McGuire; A Hantel; D B Adams; M D Abeloff; David S Ettinger
Phase I and pharmacokinetic study of brequinar sodium (NSC 368390).
Cancer research 1990;50(15):4595-9.
1990: M J Kennedy; Ross C Donehower; Louise B. Grochow; David S Ettinger; John H Fetting; M D Abeloff
Phase II trial of menogaril as initial chemotherapy for metastatic breast cancer.
Investigational new drugs 1990;8(3):289-94.
1990: A Hantel; Ross C Donehower; Eric K Rowinsky; E Vance; B V Clarke; W P McGuire; David S Ettinger; D A Noe; Louise B. Grochow
Phase I study and pharmacodynamics of piroxantrone (NSC 349174), a new anthrapyrazole.
Cancer research 1990;50(11):3284-8.
1990: David S Ettinger; D M Finkelstein; M D Abeloff; Y C Chang; T J Smith; M M Oken; John Ruckdeschel
Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer.
Investigational new drugs 1990;8(2):183-5.
1990: Lynn Schuchter; C B Hendricks; K H Holland; B K Shelton; Grover M Hutchins; K L Baughman; David S Ettinger
Eosinophilic myocarditis associated with high-dose interleukin-2 therapy.
The American journal of medicine 1990;88(4):439-40.
1990: David S Ettinger
Systemic and combined modality therapy for lung cancer.
Maryland medical journal (Baltimore, Md. : 1985) 1990;39(4):315-6.
1990: Seena Aisner; D M Finkelstein; David S Ettinger; M D Abeloff; John Ruckdeschel; J C Eggleston
The clinical significance of variant-morphology small-cell carcinoma of the lung.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(3):402-8.
1990: David S Ettinger
Evaluation of new drugs in untreated patients with small-cell lung cancer: its time has come.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(3):374-7.
1990: David S Ettinger; D M Finkelstein; M D Abeloff; John Ruckdeschel; Seena Aisner; J C Eggleston
A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(2):230-40.
1989: Eric K Rowinsky; Louise B. Grochow; A Hantel; David S Ettinger; B L Vito; Ross C Donehower
Assessment of N-methylformamide (NMF) administered orally on a three times weekly schedule: a phase I study.
Investigational new drugs 1989;7(4):317-25.
1989: W P McGuire; Eric K Rowinsky; Neil B Rosenshein; F C Grumbine; David S Ettinger; Deborah K Armstrong; Ross C Donehower
Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms.
Annals of internal medicine 1989;111(4):273-9.
1989: Eric K Rowinsky; PJ Burke; Judith E Karp; R W Tucker; David S Ettinger; Ross C Donehower
Phase I and pharmacodynamic study of taxol in refractory acute leukemias.
Cancer research 1989;49(16):4640-7.
1989: David S Ettinger
Ifosfamide in the treatment of non-small cell lung cancer.
Seminars in oncology 1989;16(1 Suppl 3):31-8.
1989: Louise B. Grochow; D A Noe; G B Dole; Eric K Rowinsky; David S Ettinger; M L Graham; W P McGuire; Ross C Donehower
Phase I trial of trimetrexate glucuronate on a five-day bolus schedule: clinical pharmacology and pharmacodynamics.
Journal of the National Cancer Institute 1989;81(2):124-30.
1989: Louise B. Grochow; D A Noe; David S Ettinger; Ross C Donehower
A phase I trial of trimetrexate glucuronate (NSC 352122) given every 3 weeks: clinical pharmacology and pharmacodynamics.
Cancer chemotherapy and pharmacology 1989;24(5):314-20.
1989: David S Ettinger; D M Finkelstein; Ross C Donehower; ALEX CHANG; M Green; R Blum; Richard G Hahn; John Ruckdeschel
Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): an Eastern Cooperative Oncology Group study.
Medical and pediatric oncology 1989;17(3):197-201.
1988: A Hantel; Eric K Rowinsky; D A Noe; W P McGuire; Louise B. Grochow; B L Vito; David S Ettinger; Ross C Donehower
Clinical and pharmacologic reappraisal of dichloromethotrexate.
Journal of the National Cancer Institute 1988;80(19):1547-53.
1988: R A Beveridge; Daniel W Chan; Debra J Bruzek; D Damron; K R Bray; P K Gaur; David S Ettinger; R C Rock; M S Shurbaji; Francis P Kuhajda
A new biomarker in monitoring breast cancer: CA 549.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(12):1815-21.
1988: Daniel W Chan; R A Beveridge; Debra J Bruzek; D J Damron; K R Bray; P K Gaur; David S Ettinger; R C Rock
Monitoring breast cancer with CA 549.
Clinical chemistry 1988;34(10):2000-4.
1988: Eric K Rowinsky; D A Noe; D W Orr; Louise B. Grochow; David S Ettinger; Ross C Donehower
Clinical pharmacology of oral and i.v. N-methylformamide: a pharmacologic basis for lack of clinical antineoplastic activity.
Journal of the National Cancer Institute 1988;80(9):671-8.
1988: David S Ettinger; K Harwood
Phase II study of recombinant beta interferon in patients with advanced non-small-cell lung carcinoma.
Medical and pediatric oncology 1988;16(1):30-2.
1987: Ross C Donehower; eric rowinsky; Louise B. Grochow; S M Longnecker; David S Ettinger
Phase I trial of taxol in patients with advanced cancer.
Cancer treatment reports 1987;71(12):1171-7.
1987: eric rowinsky; David S Ettinger; W P McGuire; D A Noe; Louise B. Grochow; Ross C Donehower
Prolonged infusion of hexamethylene bisacetamide: a phase I and pharmacological study.
Cancer research 1987;47(21):5788-95.
1987: David S Ettinger; P M Wilcox
Benign breast disorders: a symptomatic approach.
Hospital practice (Office ed.) 1987;22(9A):75-7, 80-2.
1987: Ross C Donehower; N B Rosenshein; J Rotmensch; David S Ettinger
Sequential methotrexate and 5-fluorouracil in advanced ovarian carcinoma.
Gynecologic oncology 1987;27(1):90-6.
1987: eric rowinsky; W P McGuire; Grant J Anhalt; David S Ettinger; Ross C Donehower
Hexamethylene bisacetamide-induced cutaneous vasculitis.
Cancer treatment reports 1987;71(5):471-4.
1987: R. Robinson Baker; David S Ettinger; J D Ruckdeschel; J C Eggleston; M F McKneally; M D Abeloff; J Woll; D J Adelstein
The role of surgery in the management of selected patients with small-cell carcinoma of the lung.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(5):697-702.
1987: G B Stillwagon; S E Order; J L Klein; PK Leichner; S A Leibel; Stanley S Siegelman; elliot fishman; David S Ettinger; TL Haulk; K Kopher
Multi-modality treatment of primary nonresectable intrahepatic cholangiocarcinoma with 131I anti-CEA--a Radiation Therapy Oncology Group Study.
International journal of radiation oncology, biology, physics 1987;13(5):687-95.
1987: eric rowinsky; K V Harwood; David S Ettinger
Sudden dyspnea occurring 24 hours after mitomycin plus etoposide combination therapy.
Cancer treatment reports 1987;71(1):103-4.
1987: T D Brown; Ross C Donehower; Louise B. Grochow; A P Rice; David S Ettinger
A phase I study of menogaril in patients with advanced cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(1):92-9.
1987: S M Longnecker; Ross C Donehower; A E Cates; T L Chen; R B Brundrett; Louise B. Grochow; David S Ettinger; M Colvin
High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial.
Cancer treatment reports 1987;71(1):53-9.
1986: eric rowinsky; David S Ettinger; Louise B. Grochow; R B Brundrett; A E Cates; Ross C Donehower
Phase I and pharmacologic study of hexamethylene bisacetamide in patients with advanced cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(12):1835-44.
1986: David S Ettinger; J Allegra; J R Bertino; P Bonomi; H Browder; P Byrne; J Carpenter; R Catalano; R Creech; B Dana
Megestrol acetate v tamoxifen in advanced breast cancer: correlation of hormone receptors and response.
Seminars in oncology 1986;13(4 Suppl 4):9-14.
1986: P D Bonomi; R Pazdur; L Stolbach; B Mason; David S Ettinger
Phase II trial of mitomycin, vindesine, and hexamethylmelamine in metastatic non-small cell bronchogenic carcinoma.
Cancer treatment reports 1986;70(12):1447-8.
1986: T D Brown; David S Ettinger; Ross C Donehower
A phase I trial of spirohydantoin mustard (NSC 172112) in patients with advanced cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(8):1270-6.
1986: M Hitt; David S Ettinger
Toad toxicity.
The New England journal of medicine 1986;314(23):1517-8.
1986: D M Finkelstein; David S Ettinger; John Ruckdeschel
Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(5):702-9.
1986: I N Olver; Ross C Donehower; David A Van Echo; David S Ettinger; Joseph Aisner
Phase II trial of carboplatin in non-small cell lung cancer.
Cancer treatment reports 1986;70(3):421-2.
1986: John Ruckdeschel; D M Finkelstein; David S Ettinger; R H Creech; B A Mason; R A Joss; S Vogl
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(1):14-22.
1986: S E Order; J L Klein; PK Leichner; David S Ettinger; K Kopher; K Finney; M Surdyke; S A Leibel
Radiolabeled antibody in the treatment of primary and metastatic liver malignancies.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1986;100():307-14.
1985: S E Order; G B Stillwagon; J L Klein; PK Leichner; Stanley S Siegelman; elliot fishman; David S Ettinger; TL Haulk; K Kopher; K Finney
Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(12):1573-82.
1985: K J Pandya; F M Muggia; R T Skeel; G Falkson; B M Kaplan; David S Ettinger
A phase II study of bisantrene in advanced refractory breast cancer. An Eastern Cooperative Oncology Group pilot study.
American journal of clinical oncology 1985;8(5):353-7.
1985: David S Ettinger; P K Leichner; Stanley S Siegelman; elliot fishman; J L Klein; S E Order
Computed tomography assisted volumetric analysis of primary liver tumor as a measure of response to therapy.
American journal of clinical oncology 1985;8(5):413-8.
1985: David S Ettinger; D M Finkelstein; G R Harper; John Ruckdeschel; ALEX CHANG; F J Camacho; J C Marsh; R Silber; J M Wolter
Phase II study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study.
Cancer treatment reports 1985;69(9):1033-4.
1985: Georgia B Vogelsang; M D Abeloff; David S Ettinger; S V Booker
Long-term survivors of small cell carcinoma of the lung.
The American journal of medicine 1985;79(1):49-56.
1985: David S Ettinger; D W Orr; A P Rice; Ross C Donehower
Phase I study of N-methylformamide in patients with advanced cancer.
Cancer treatment reports 1985;69(5):489-93.
1985: M D Abeloff; D M Finkelstein; ALEX CHANG; F J Camacho; R H Creech; David S Ettinger
Phase II study of aclarubicin and diaziquone in the treatment of advanced small cell bronchogenic carcinoma (EST 4581): an Eastern Cooperative Oncology Group Study.
Cancer treatment reports 1985;69(4):451-2.
1985: EVA ZINREICH; R. Robinson Baker; David S Ettinger; S E Order
New frontiers in the treatment of lung cancer.
Critical reviews in oncology/hematology 1985;3(4):279-308.
1984: David S Ettinger; D Tritchler; R Earhart; R H Creech
Phase II study of PALA and PCNU in the treatment of non-small cell lung cancer (EST 2580): an Eastern Cooperative Oncology Group study.
Cancer treatment reports 1984;68(10):1297-8.
1984: R H Creech; D Tritchler; David S Ettinger; J A Ferraro; John Ruckdeschel; S E Vogl; J Woll
Phase II study of PALA, amsacrine, teniposide, and zinostatin in small cell lung carcinoma (EST 2579).
Cancer treatment reports 1984;68(9):1183-4.
1984: M Markman; V Sheidler; David S Ettinger; SA Quaskey; E D Mellits
Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy.
The New England journal of medicine 1984;311(9):549-52.
1984: V R Sheidler; David S Ettinger; R B Diasio; J P Enterline; M D Brown
Double-blind multiple-dose crossover study of the antiemetic effect of intramuscular levonantradol compared to prochlorperazine.
Journal of clinical pharmacology 1984;24(4):155-9.
1984: T. WAALKES; J P Enterline; J H Shaper; M D Abeloff; David S Ettinger
Biological markers for breast carcinoma.
Cancer 1984;53(3 Suppl):644-51.
1984: P K Leichner; J L Klein; elliot fishman; Stanley S Siegelman; David S Ettinger; S E Order
Comparative tumor dose from 131I-labeled polyclonal anti-ferritin, anti-AFP, and anti-CEA in primary liver cancers.
Cancer drug delivery 1984;1(4):321-8.
1983: P K Leichner; J L Klein; Stanley S Siegelman; David S Ettinger; S E Order
Dosimetry of 131I-labeled antiferritin in hepatoma: specific activities in the tumor and liver.
Cancer treatment reports 1983;67(7-8):647-58.
1983: T. WAALKES; M D Abeloff; David S Ettinger; K B Woo; K C Kuo; C W Gehrke
Serum protein-bound carbohydrates and small cell carcinoma of the lung. Correlations with extent of disease, tumor burden, survival, and clinical response categories.
Cancer 1983;52(1):131-9.
1983: A W Berkman; J J Woog; Thomas S Kickler; David S Ettinger
Serial determinations of antiplatelet antibodies in a patient with Hodgkin's disease and autoimmune thrombocytopenia.
Cancer 1983;51(11):2057-60.
1983: E J Reddick; David S Ettinger; W C Madauss
Dermoid cysts of the anterior fontanelle: case reports.
Military medicine 1983;148(6):548-50.
1983: David S Ettinger; R Day; J A Ferraro; John Ruckdeschel; J E Woll; R H Creech; S E Vogl
A randomized phase II study of m-AMSA (NSC 249992) and neocarzinostatin (NSC 157365) in non-small cell bronchogenic carcinoma. An Eastern Cooperative Group Study.
American journal of clinical oncology 1983;6(2):167-70.
1983: A G Meek; S E Order; M D Abeloff; David S Ettinger; R. Robinson Baker; E Baral
Concurrent radiochemotherapy in advanced breast cancer.
Cancer 1983;51(6):1001-6.
1983: Enrique Hernandez; Neil B Rosenshein; J Villar; M B Dillon; David S Ettinger; S E Order
Alternating multiagent chemotherapy for advanced ovarian cancer.
Journal of surgical oncology 1983;22(2):87-91.
1983: Kell Osterlind; D C Ihde; David S Ettinger; R J Gralla; K Karrer; S Krauss; L H Maurer; M Rørth; S Sörenson; R Vincent
Staging and prognostic factors in small cell carcinoma of the lung.
Cancer treatment reports 1983;67(1):3-9.
1982: T. WAALKES; N B Rosenshein; J H Shaper; David S Ettinger; K B Woo; J F Paone; C W Gehrke
A feasibility study in the development of biological markers for ovarian cancer.
Journal of surgical oncology 1982;21(4):207-14.
1982: T. WAALKES; M D Abeloff; David S Ettinger; K B Woo; C W Gehrke; K C Kuo; E Borek
Modified ribonucleosides as biological markers for patients with small cell carcinoma of the lung.
European journal of cancer & clinical oncology 1982;18(12):1267-74.
1982: T. WAALKES; M D Abeloff; David S Ettinger; K B Woo; C W Gehrke; K C Kuo; E Borek
Biological markers and small cell carcinoma of the lung: a clinical evaluation of urinary ribonucleosides.
Cancer 1982;50(11):2457-64.
1982: Enrique Hernandez; Neil B Rosenshein; J Pino y Torres; J Villar; F C Grumbine; David S Ettinger; M B Dillon; J L Klein; S E Order
Ip immunotherapy and chemotherapy in advanced epithelial ovarian cancer.
Cancer treatment reports 1982;66(11):1981-2.
1982: J L Pino y Torres; D S Bross; Enrique Hernandez; Neil B Rosenshein; J L Klein; David S Ettinger; P K Leichner; S E Order
Multimodality treatment of patients with advanced ovarian carcinoma.
International journal of radiation oncology, biology, physics 1982;8(10):1671-7.
1982: W E Delaney; E Nickoloff; David S Ettinger; H M Drew; D J Szeluga; Robert Stuart
Abnormal fatty acid breath tests in cancer patients, with nutritional correlation.
Cancer 1982;50(4):727-31.
1982: John H Fetting; Louise B. Grochow; MARSHAL FOLSTEIN; David S Ettinger; M Colvin
The course of nausea and vomiting after high-dose cyclophosphamide.
Cancer treatment reports 1982;66(7):1487-93.
1982: R H Creech; K Stanley; S E Vogl; David S Ettinger; P D Bonomi; O Salazar
Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578).
Cancer treatment reports 1982;66(6):1417-9.
1982: T. WAALKES; M D Abeloff; David S Ettinger; J E Mrochek; W D Bostick
Biological markers as an aid in the clinical management of patients with liver metastases.
Journal of surgical oncology 1982;20(2):83-94.
1982: David S Ettinger; S Lagakos
Phase III study of CCNU, cyclophosphamide, adriamycin, vincristine, and VP-16 in small-cell carcinoma of the lung.
Cancer 1982;49(8):1544-54.
1982: David S Ettinger; S E Order; Moody D Wharam; M K Parker; J L Klein; P K Leichner
Phase I-II study of isotopic immunoglobulin therapy for primary liver cancer.
Cancer treatment reports 1982;66(2):289-97.
1982: W E Delaney; Robert Stuart; David S Ettinger
Fatty acid breath test values in the malabsorption range in cancer patients.
Nutrition and cancer 1982;3(3):122-8.
1981: K B Woo; T. WAALKES; M D Abeloff; David S Ettinger; K L McNitt; C W Gehrke
Multiple biologic markers in the monitoring of treatment for patients with small cell carcinoma of the lung: the use of serial levels of plasma CEA and serum carbohydrates.
Cancer 1981;48(7):1633-42.
1981: R B Diasio; David S Ettinger; B E Satterwhite
Oral levonantradol in the treatment of chemotherapy-induced emesis: preliminary observations.
Journal of clinical pharmacology 1981;21(8-9 Suppl):81S-85S.
1981: R D Shuman; David S Ettinger; M D Abeloff; S V Livengood; NICHOLAS FORTUIN
Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity.
The Johns Hopkins medical journal 1981;149(2):57-63.
1981: S E Order; Neil B Rosenshein; J L Klein; S Leibel; J Pino Y Torres; David S Ettinger
The integration of new therapies and radiation in the management of ovarian cancer.
Cancer 1981;48(2 Suppl):590-6.
1981: M D Abeloff; David S Ettinger; S E Order; NAGI KHOURI; E D Mellits; N T Dorschel; R Baumgardner
Intensive induction chemotherapy in 54 patients with small cell carcinoma of the lung.
Cancer treatment reports 1981;65(7-8):639-46.
1981: P K Leichner; J L Klein; J B Garrison; R E Jenkins; E L Nickoloff; David S Ettinger; S E Order
Dosimetry of 131I-labeled anti-ferritin in hepatoma: a model for radioimmunoglobulin dosimetry.
International journal of radiation oncology, biology, physics 1981;7(3):323-33.
1981: J F Paone; M D Abeloff; David S Ettinger; E A Arnold; R. Robinson Baker
The correlation of estrogen and progesterone receptor levels with response to chemotherapy for advanced carcinoma of the breast.
Surgery, gynecology & obstetrics 1981;152(1):70-4.
1981: D L Trump; David S Ettinger; M J Feldman; L H Dragon
'Sarcoidosis' and sarcoid-like lesions. Their occurrence after cytotoxic and radiation therapy of testis cancer.
Archives of internal medicine 1981;141(1):37-8.
1981: D L Trump; David S Ettinger; M D Abeloff
Doxorubicin, vincristine, and cis-diamminedichloroplatinum (II) therapy in patients with advanced breast cancer.
Medical and pediatric oncology 1981;9(1):1-3.
1981: T. WAALKES; M D Abeloff; David S Ettinger; K B Woo; C W Gehrke; J E Mrochek
Multiple biological markers and breast carcinoma: a preliminary study in the detection of recurrent disease after primary therapy.
Journal of surgical oncology 1981;18(1):9-19.
1980: T. WAALKES; M D Abeloff; K B Woo; David S Ettinger; R W Ruddon; P Aldenderfer
Carcinoembryonic antigen for monitoring patients with small cell carcinoma of the lung during treatment.
Cancer research 1980;40(12):4420-7.
1980: J B Taxy; David S Ettinger; Moody D Wharam
Primary small cell carcinoma of the skin.
Cancer 1980;46(10):2308-11.
1980: David S Ettinger; K E Stanley; J S Nystrom
Phase II study of high-dose methotrexate in the treatment of patients with non-small cell carcinoma of the lung: an Eastern Cooperative Oncology Group study.
Cancer treatment reports 1980;64(10-11):1017-21.
1980: S E Order; J L Klein; David S Ettinger; P Alderson; Stanley S Siegelman; P Leichner
Use of isotopic immunoglobulin in therapy.
Cancer research 1980;40(8 Pt 2):3001-7.
1980: A Giangreco; David S Ettinger; L H Dragon; P K Gupta; R E Lenhard
Sputum cytologic diagnosis of Hodgkin's disease involving the lung.
Archives of internal medicine 1980;140(7):910-3.
1980: S E Order; J L Klein; David S Ettinger; P Alderson; Stanley S Siegelman; P Leichner
Phase I-II study of radiolabeled antibody integrated in the treatment of primary hepatic malignancies.
International journal of radiation oncology, biology, physics 1980;6(6):703-10.
1980: David S Ettinger; N B Rosenshein; T H Parmley; G Mendelsohn; Stephen B Baylin
Tumor cell origin of histaminase activity in ascites fluid from patients with ovarian carcinoma.
Cancer 1980;45(10):2568-72.
1979: N B Rosenshein; F C Grumbine; J D Woodruff; David S Ettinger
Pregnancy following chemotherapy for an ovarian immature embryonal teratoma.
Gynecologic oncology 1979;8(2):234-9.
1979: S E Order; N B Rosenshein; J L Klein; A S Lichter; David S Ettinger; M B Dillon; S A Leibel
New methods applied to the analysis and treatment of ovarian cancer.
International journal of radiation oncology, biology, physics 1979;5(6):861-73.
1979: M D Abeloff; J C Eggleston; G Mendelsohn; David S Ettinger; Stephen B Baylin
Changes in morphologic and biochemical characteristics of small cell carcinoma of the lung. A clinicopathologic study.
The American journal of medicine 1979;66(5):757-64.
1979: C W Gehrke; T. WAALKES; E Borek; W F Swartz; T F Cole; K C Kuo; M Abeloff; David S Ettinger; N Rosenshein; R C Young
Quantitative gas-liquid chromatography of neutral sugars in human serum glycoproteins. Fucose, mannose, and galactose as predictors in ovarian and small cell lung carcinoma.
Journal of chromatography 1979;162(4):507-28.
1979: M D Abeloff; David S Ettinger; NAGI KHOURI; R E Lenhard
Intensive induction therapy for small cell carcinoma of the lung.
Cancer treatment reports 1979;63(4):519-24.
1979: David S Ettinger; P J Vitale; D L Trump
Important clinical pharmacologic considerations in the use of methadone in cancer patients.
Cancer treatment reports 1979;63(3):457-9.
1979: W P Vaughan; P M Wilcox; P O Alderson; David S Ettinger; M D Abeloff
Hepatic toxicity of adjuvant chemotherapy for carcinoma of the breast.
Medical and pediatric oncology 1979;7(4):351-9.
1979: David S Ettinger; L H Dragon; J Klein; M Sgagias; S E Order
Isotopic immunoglobulin in an integrated multimodal treatment program for a primary liver cancer: a case report.
Cancer treatment reports 1979;63(1):131-4.
1978: Stephen B Baylin; W R Weisburger; J C Eggleston; G Mendelsohn; M A Beaven; M D Abeloff; David S Ettinger
Variable content of histaminase, L-dopa decarboxylase and calcitonin in small-cell carcinoma of the lung. Biologic and clinical implications.
The New England journal of medicine 1978;299(3):105-10.
1978: David S Ettinger; W G Harker; H W Gerry; R C Sanders; R Saral
Hyperphosphatemia, hypocalcemia, and transient renal failure. Results of cytotoxic treatment of acute lymphoblastic leukemia.
JAMA : the journal of the American Medical Association 1978;239(23):2472-4.
1978: David S Ettinger; Stephen B Baylin; D Minaberry; M D Abeloff; E D Mellits
Response of plasma histaminase activity to heparin in normal subjects and in patients with small cell carcinoma of the lung.
Journal of the National Cancer Institute 1978;60(6):1239-42.
1978: David S Ettinger; Judith E Karp; M D Abeloff; P J Burke; H G Braine
Intermittent high-dose cyclophosphamide chemotherapy for small cell carcinoma of the lung.
Cancer treatment reports 1978;62(3):413-24.
1977: M D Abeloff; David S Ettinger
Treatment of metastatic breast cancer with adriamycin-cyclophosphamide induction followed by alternating combination therapy.
Cancer treatment reports 1977;61(9):1685-9.
1977: P M Wilcox; David S Ettinger
Benign breast disease. Diagnosis and treatment.
Primary care 1977;4(4):739-54.
1977: David S Ettinger; D Carter
Gastric carcinoma 16 years after gastric lymphoma irradiation.
The American journal of gastroenterology 1977;68(5):485-8.
1977: David S Ettinger; R E Slavin
Chronic radiation enteritis complicating non-Hodgkin's lymphoma.
Southern medical journal 1977;70(5):637-9.
1977: David S Ettinger; T H Parmley; R J Owellen; T E Davis
Endodermal sinus tumor. Report of a case with remission following chemotherapy.
Obstetrics and gynecology 1977;49(1 suppl):53-5.
1976: S D Prystowsky; Bert Vogelstein; David S Ettinger; William G Merz; H Kaizer; V I Sulica; W H Zinkham
Invasive aspergillosis.
The New England journal of medicine 1976;295(12):655-8.
1976: M D Abeloff; David S Ettinger; Stephen B Baylin; T Hazra
Management of small cell carcinoma of the lung: therapy, staging, and biochemical markers.
Cancer 1976;38(3):1394-401.
1975: Stephen B Baylin; M D Abeloff; K C Wieman; J W Tomford; David S Ettinger
Elevated histaminase (diamine oxidase) activity in small-cell carcinoma of the lung.
The New England journal of medicine 1975;293(25):1286-90.
1975: David S Ettinger; RICHARD HUMPHREY; M D Skinner
Kaposi's sarcoma associated with multiple myeloma.
The Johns Hopkins medical journal 1975;137(2):88-90.